wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q33942806-07670492-CEB9-4672-BBE7-E455D7706A49
Q33942806-07670492-CEB9-4672-BBE7-E455D7706A49
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33942806-07670492-CEB9-4672-BBE7-E455D7706A49
Enhancement of antitumor effect using dendritic cells activated with natural killer cells in the presence of Toll-like receptor agonist.
P2860
Q33942806-07670492-CEB9-4672-BBE7-E455D7706A49
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33942806-07670492-CEB9-4672-BBE7-E455D7706A49
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
e80e38cf75c2c72f2187fafc9d9263e2ea99a5d7
P2860
Phase II clinical trial results involving treatment with low-dose daily oral cyclophosphamide, weekly vinblastine, and rofecoxib in patients with advanced solid tumors.